Richard Kadota

2.2k citations
46 papers · 1.6k indexed · h-index 22
Topics
Glioma Diagnosis and Treatment (19 papers)Acute Lymphoblastic Leukemia research (19 papers)Acute Myeloid Leukemia Research (11 papers)

In The Last Decade

Richard Kadota

45 papers receiving 1.5k citations

Peers

Richard Kadota
Comparison fields: 5 of 80
  • Genetics 698
  • Neurology 525
  • Hematology 449
  • Public Health, Environmental and Occupational Health 423
  • Molecular Biology 361
Replace Renato Mastrangelo with:
Renato Mastrangelo Italy
Mars B. van ’t Veer Netherlands
André Baruchel France
Minnie Abromowitch United States
J Ochs United States
Ho‐Jin Shin South Korea
W. Paul Bowman United States
Rik Schots Belgium
Vita J. Land United States
J J Shuster United States
Richard Kadota relative to Renato Mastrangelo Italy Renato Mastrangelo's profile →
Citations per field
00.5×6.8×
Renato Mastrangelo · 1×
Citations per year

Countries citing papers authored by Richard Kadota

Since Specialization
Citations

This map shows the geographic impact of Richard Kadota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Kadota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Kadota more than expected).

Fields of papers citing papers by Richard Kadota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Kadota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Kadota. The network helps show where Richard Kadota may publish in the future.

Co-authorship network of co-authors of Richard Kadota

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Kadota. A scholar is included among the top collaborators of Richard Kadota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Kadota. Richard Kadota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 89
2 19
3 2
4 8
5 28
6 82
7 22
8 4
9 138
10 215
11 35
12 23
13 45
14 23
15 16
16 47
17 5
18 6
19 11
20 32

About Richard Kadota

Richard Kadota is a scholar working on Genetics, Hematology and Neurology, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (19 papers) and Acute Myeloid Leukemia Research (11 papers). The work is most often cited by research in Genetics (698 citations), Hematology (449 citations) and Neurology (525 citations). Richard Kadota has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Henry S. Friedman, Sima Jeha, Peter G. Steinherz, Paul S. Gaynon, Lisa Bomgaars, James L. Kepner, Michael Rytting, Mark Krailo, Mark L. Bernstein and Peter C. Burger. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026